Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical ...
Despite generic headwinds to Xarelto and challenges across different sectors of the conglomerate suggesting “twists and turns ...
A team of researchers have applied a novel blood test that can detect early signs of potentially fatal lung damage in cancer ...
In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...
The Brighterside of News on MSN1d
Anti-cancer drug shows incredible promise in human clinical trialsFor decades, the medical world has avidly searched for groundbreaking treatments against one of humanity’s most resilient ...
Syndax Pharmaceuticals (SNDX) stock dropped ~23% after the company posted Phase 2 trial data for its AML candidate, revumenib ...
University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. Jill ...
Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...
In addition to developing WU-CART-007, a drug candidate in clinical trials for treating relapsed ... T-cell acute ...
New study introduces a simple blood test to detect early lung damage in cancer patients receiving novel therapy with ...
Investigator Studies Program with the provision of study drug and financial support. Additional funding was provided by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback